Drug to prevent strokes is successful in trials
Two of the company's biggeset drug companies are closer to commercializing a drug that would reduce the risk of stroke for people with irregular heartbeats by preventing blood clots.
Pfizer Inc. and Bristol-Myers Squibb Co. said they had stopped a joint clinical trial on the drug, named apixaban, because there was enough evidence to prove it worked.
The drug companies have been testing the drug on 5,600 patients in 36 countries since September. The study was coordinated by the Population Health Research Institute.
About 2.3 million people in the United States suffer from irregular heartbeats, according to the companies. Nearly 2 million people develop blood clots in large veins of the body that can break free and lodge in the lungs, potentially resulting in death.
Current drugs to prevent blood clots don't work on all patients with the heart condition.









Comments
Just what we need, yet another drug to prevent drug clots. Only how much will this one cost ??
Posted by: karen | June 19, 2010 11:09 AM